Last updated on July 2018

Thrombosomes in Bleeding Thrombocytopenic Patients

Brief description of study

This study evaluates in a dose-escalation manner, the safety, and preliminary impact on bleeding, and the preliminary effect on coagulation measures of increasing doses of allogeneic Thrombosomes in thrombocytopenic patients.

Detailed Study Description

The objectives of this trial, conducted in thrombocytopenic patients with modified World Health Organization (WHO) Grade 1* or 2 bleeding, assessing the safety of infusing increasing doses of allogeneic Thrombosomes in WHO bleeding and measures of coagulation.

Clinical Study Identifier: NCT03394755

Contact Investigators or Research Sites near you

Start Over

Jose Cancelas, MD, PhD

Hoxworth Blood Center
Cincinnati, OH United States
  Connect »

Vinod Pullarkat, MD

City of Hope
Duarte, CA United States
  Connect »

Robertson Davenport, MD

University of Michigan
Ann Arbor, MI United States
  Connect »

Zbigniew (Ziggy) Szczepiorkowski, MD, PhD

Dartmouth Hitchcock Medical Center
Lebanon, NH United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.